Target occupancy study and whole-body dosimetry with a MAGL PET ligand [<sup>11</sup>C]PF-06809247 in non-human primates.

Arakawa, Ryosuke; Takano, Akihiro; Nag, Sangram; Jia, Zhisheng; Amini, Nahid; Maresca, Kevin P; Zhang, Lei; Keliher, Edmund J; Butler, Christopher R; Piro, Justin R; Samad, Tarek A; Smith, Deborah; Nason, Deane; O'Neil, Steve; Trapa, Patrick; Fonseca, Kari R; Litchfield, John; McCarthy, Timothy; Carson, Richard E; Halldin, Christer

Target occupancy study and whole-body dosimetry with a MAGL PET ligand [¹¹C]PF-06809247 in non-human primates.

Arakawa, Ryosuke; Takano, Akihiro; Nag, Sangram; Jia, Zhisheng; Amini, Nahid; Maresca, Kevin P; Zhang, Lei; Keliher, Edmund J; Butler, Christopher R; Piro, Justin R; Samad, Tarek A; Smith, Deborah; Nason, Deane; O'Neil, Steve; Trapa, Patrick; Fonseca, Kari R; Litchfield, John; McCarthy, Timothy; Carson, Richard E; Halldin, Christer.

Afiliação

Arakawa R; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden. ryosuke.arakawa@ki.se.
Takano A; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden. ryosuke.arakawa@ki.se.
Nag S; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden.
Jia Z; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Amini N; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden.
Maresca KP; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Zhang L; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden.
Keliher EJ; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Butler CR; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Solna, R5:02, 17176, Stockholm, Sweden.
Piro JR; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Samad TA; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
Smith D; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
Nason D; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
O'Neil S; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
Trapa P; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
Fonseca KR; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
Litchfield J; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
McCarthy T; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
Carson RE; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
Halldin C; Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.